Transgender Candidate Has Uphill Battle Against Vermont Incumbent
*By Christian Smith*
Christine Hallquist, the first transgender gubernatorial candidate to be nominated by a major party, faces an uphill battle in Vermont, where she is trying to unseat the popular Republican governor.
"It's possible, but not likely, that Vermont will have the first transgender governor because the incumbent there, Phil Scott, is very popular," said Jonathan Alter, a political reporter and the host of Sirius XM's Alter Family Politics.
Hallquist, the former CEO of Vermont Electric Cooperative, won 48.3 percent in Tuesday's Democratic [primary](https://www.nytimes.com/interactive/2018/08/14/us/elections/results-vermont-primary-elections.html). She beat out three other candidates, including a 14-year-old boy who was allowed to run because the Vermont Constitution does not have an age requirement for gubernatorial candidates.
"As far as I'm concerned, these are nice breakthroughs," Alter said Wednesday in an interview on Cheddar. "But they're not ultimately nearly as important as what happens between now and November. The big question is, whether Democrats ー progressives, in particular ー people who don't always vote very much, whether they get off their duffs, turn off their cable TV, go out there, and not actually vote, but work in flippable districts in their states."
Scott, who is popular even among Democrats in Vermont, is considered the favorite to win, though his poll numbers have taken a hit in recent months. His approval rating fell 18 points to 47 percent, and his disapproval rating doubled to 42 percent, according to Morning Consult's latest [quarterly governor approval rankings](https://morningconsult.com/2018/07/25/americas-most-and-least-popular-governors-2/).
The drop came after Scott [tightened](https://www.cnn.com/2018/03/09/us/florida-gov-scott-gun-bill/index.html) gun control laws in March. Despite Vermont's reputation as a liberal state, nearly a third of its residents own guns, according to [CBS News](https://www.cbsnews.com/pictures/gun-ownership-rates-by-state/20/).
For more on this story, [click here](https://cheddar.com/videos/do-democrats-have-what-it-takes-to-take-back-congress-in-november).
Jill and Carlo cover the latest on Omicron, another school shooting in America and more. Plus, bidding farewell to 'transitory' inflation, and the controversy surrounding 'Lovely Bones' author Alice Sebold.
Disparities in tree coverage across America is a huge issue that affects air quality, heat exposure, and ultimately determines how resilient communities are against climate change. The Build Back Better Act is allocating $2.5 billion to boost 'tree equity.' Lemir Teron, assistant professor at SUNY College of Environmental Science and Forestry, joins Cheddar News to explain why this is a priority for Democrats today.
The Supreme Court will be hearing arguments in Dobbs v. Jackson Women's Health on Wednesday over a Mississippi law banning abortions after 15 weeks. Jimmy Hoover, the Supreme Court editor-at-large for Law360, joined Cheddar to break down the momentous legal fight. "This is the biggest abortion case at the Supreme Court in 30 years," he said. "It is a … a direct challenge to Roe v. Wade."
Matt Peron, Director of Research at Janus Henderson Investors, joins Cheddar News' Closing Bell, where he breaks down the factors leading to today's market slide and says there's more to it than Fed Chair Jerome Powell's comments about speeding up tapering efforts.
Walmart CEO Dough McMillon praised the Biden administration's efforts to ease supply chain constraints after the company saw a 26 percent jump in shipments over the last month. President Joe Biden had announced back in October that California ports would operate on a 24/7 basis.
Jill and Carlo cover the latest developments with the Omicron variant that are spooking markets once again. Twitter's @Jack is leaving, SCOTUS takes up abortion rights and the world has a brand new republic.
The Biden Administration is set to buy 10 million courses of Pfizer's Covid pill if it gains emergency use authorization from the FDA. With this purchase, the U.S. will receive more than 13 million courses of antiviral pills aimed at treating Covid and reducing severe illness and death. Pfizer's pill has been shown to reduce risk of hospitalization and death by 89 percent, proving it could be a key tool in the fight against the pandemic. Dr. Soumi Eachempati, Co-Founder, CEO & CMO of Cleared4, joined Cheddar News to discuss.
